atorvastatin has been researched along with Ototoxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, P; Brewer, C; Campbell, M; Cheng, H; Clements, A; Cunningham, LL; Dubno, JR; Fernandez, KA; Garrett, J; Li, CM; Mulford, D; Mulquin, M; Newlands, S; Ortiz, C; Page, B; Schmitt, NC; Townes, T | 1 |
1 trial(s) available for atorvastatin and Ototoxicity
| Article | Year |
|---|---|
Atorvastatin is associated with reduced cisplatin-induced hearing loss.
Topics: Aged; Atorvastatin; Cisplatin; Female; Head and Neck Neoplasms; Hearing Loss; Humans; Incidence; Male; Middle Aged; Ototoxicity; Prospective Studies; Retrospective Studies | 2021 |